{
  "meta": {
    "title": "7_Elimination_Round",
    "url": "https://brainandscalpel.vercel.app/7-elimination-round-e8238213.html",
    "scrapedAt": "2025-11-29T17:24:10.608Z"
  },
  "questions": [
    {
      "id": 25923,
      "choices": [
        {
          "id": 103638,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Her risk of a thromboembolism is only elevated if she tests positive for antiphospholipid antibodies, which is only seen in 10% of lupus patients.</span></span></p>"
        },
        {
          "id": 103639,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Her risk of a thromboembolism is only elevated if she tests positive for antiphospholipid antibodies, which is seen in about one-third of lupus patients.</span></span></p>"
        },
        {
          "id": 103640,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Having SLE even without antiphospholipid antibodies is a significant risk factor for developing a blood clot</span></span></p>"
        },
        {
          "id": 103641,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The longer one has had SLE, the higher the risk for a thromboembolism</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 37-year-old woman with a SLE presents for a routine follow up visit. She is compliant with her medication regimen containing hydroxychloroquine. An old friend of hers from high school recently passed away from a sudden pulmonary embolism, and the situation made her worried. She asks if she is at risk for a blood clot. What should you tell her?</span></span></p>",
      "unique_key": "Q6441712",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198900,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. Having SLE even without antiphospholipid antibodies is a significant risk factor for developing a blood clot</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">While testing positive for antiphospholipid antibodies puts a patient at a particularly high risk for developing a thromboembolism, even SLE patients without antiphospholipid antibodies are at an increased risk of developing a blood clot. Acquired protein S deficiency and inflammation, in general, are thought to play a role in the pathophysiology. Anywhere from 10 to 26% of lupus patients will develop a blood clot.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Incorrect Answers:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A. Simply having lupus, regardless of the presence of antiphospholipid antibodies, is a risk factor for developing a blood clot. Approximately one-third of patients with SLE will test positive for antiphospholipid antibodies.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">B. Although it is true that one-third of lupus patients will test positive for antiphospholipid antibodies, the other two-thirds are still at an increased risk for developing a blood clot.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">D. One study showed that a lupus patient&rsquo;s risk for developing a blood clot is highest immediately after diagnosis, another study showed that the risk remains elevated for the remainder of the disease course. Regardless, it is not thought that the risk for a blood clot increases with time after the diagnosis.</span></span></p>",
      "correct_choice_id": 103640,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25925,
      "choices": [
        {
          "id": 103646,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Rupture of the extensor pollicis longus (EPL) tendon</span></span></p>"
        },
        {
          "id": 103647,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Rupture of the extensor indicis proprius (EIP) tendon</span></span></p>"
        },
        {
          "id": 103648,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Missed scaphoid fracture</span></span></p>"
        },
        {
          "id": 103649,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">De Quervain&#39;s tenosynovitis</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A previously healthy 41-year-old man suffers a minimally displaced distal radius fracture and is treated in a cast tor 4 weeks. He presents 14 weeks later with dorsal wrist pain. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q7603978",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198902,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A. Rupture of the extensor pollicis longus (EPL) tendon</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">EPL rupture is seen more commonly with undisplaced distal radial fractures, rather than displaced ones. It is thought that this is due to either a mechanical attrition of the tendon or a local area of ischaemia in the tendon. Repair is not usually possible and treatment is with tendon transfer (EIP to EPL). </span></span></p>",
      "correct_choice_id": 103646,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25927,
      "choices": [
        {
          "id": 103654,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Inhibits osteoblast production and differentiation</span></span></p>"
        },
        {
          "id": 103655,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Uncouples bone remodeling and shortens bone remodeling cycle</span></span></p>"
        },
        {
          "id": 103656,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Release of tumor necrosis factor a and interleukins IL-1 and IL-6</span></span></p>"
        },
        {
          "id": 103657,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Increased FSH production</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">By which of the following mechanisms can hyperthyroidism and thyrotoxicosis increase the risk of osteoporosis in this patient?</span></span></p>",
      "unique_key": "Q2924991",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198904,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. Uncouples bone remodeling and shortens bone remodeling cycle</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hyperthyroidism causes osteoporosis by uncoupling bone remodeling and by shortening the bone remodeling cycle.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Incorrect Answers:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A. This is a mechanism responsible for increased risk of osteoporosis due to glucocorticoids.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">C. Thyrotoxicosis causes uncoupling of bone remodeling and shortened bone remodeling cycle.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">D. This is one of the mechanisms by which menopause results in increased bone resorption and loss.</span></span></p>",
      "correct_choice_id": 103655,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25928,
      "choices": [
        {
          "id": 103658,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Pamidronate</span></span></p>"
        },
        {
          "id": 103659,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Zoledronic acid</span></span></p>"
        },
        {
          "id": 103660,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Denosumab</span></span></p>"
        },
        {
          "id": 103661,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ibandronate</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A patient with metastatic prostate cancer develops hypocalcemia during treatment with a bone antiresorptive agent. Which of the following agents is most likely to result in hypocalcemia?</span></span></p>",
      "unique_key": "Q4535970",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198905,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. Denosumab</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Denosumab is a human monoclonal antibody that binds to the receptor activator of nuclear factor-KB ligand (RANKL), to inhibit osteoclastic resorption of bone. RANKL plays a key role in regulation of osteoclast formation, function, and survival.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Bone contributes to regulation of calcium and phosphate homeostasis, so inhibition of osteoclastic activity with an antiresorptive agent increases the risk of hypocalcemia. Denosumab is a more potent osteoclast inhibitor than bisphosphonate agents and hypocalcemia is more likely in patients who are treated this agent.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Calcium and vitamin D levels should be assessed before initiating therapy with any antiresorptive agent, with supplementation of low levels prior to initiation of treatment when indicated. Periodic monitoring is recommended during therapy. Compensatory mechanisms, including increased release of parathyroid hormone, contribute to maintenance of calcium and phosphorus homeostasis. In patients who have renal insufficiency or a disorder of mineral metabolism, levels should be checked within two weeks of initiation of therapy and more frequently thereafter.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Unless there is a contraindication, most patients should receive a total of 1000 mg of calcium (diet plus supplement) and 800 to 1200 IU of vitamin D daily during treatment with an antiresorptive agent.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Incorrect Answers:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A. Pamidronate is a bisphosphonate. Although it may result in hypocalcemia, hypophosphatemia, hypomagnesemia, and hypokalemia, denosumab is a more potent inhibitor of osteoclastic resorption of bone associated with a higher risk of hypocalcemia.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">B. Zoledronic acid is a bisphosphonate and the risk of hypocalcemia and hypophosphatemia are lower with this agent compared to denusomab. Median time to initial occurrence of hypocalcemia for denusomab was also shorter, at 3.8 months compared to 6.5 months with zoledronic acid.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">D. Ibandronate is a bisphosphonate derivative that has been infrequently associated with hypocalcemia in post-marketing studies and case reports.</span></span></p>",
      "correct_choice_id": 103660,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25933,
      "choices": [
        {
          "id": 103678,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wiscott-Aldrich syndrome </span></span></p>"
        },
        {
          "id": 103679,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ataxia telangiectasia </span></span></p>"
        },
        {
          "id": 103680,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperimmunoglobulinemia E syndrome </span></span></p>"
        },
        {
          "id": 103681,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chediak-Higashi syndrome </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 7-year-old boy presents with recurrent skin infections and a history of easy bruising. On examination, the boy has patches of atopic dermatitis with overlying purpuric excoriations. Additionally, multiple molluscum contagiosum, verruca plana, and areas suggestive of eczema herpeticum are seen. Laboratory findings reveal thrombocytopenia. The patient&#39;s maternal uncle had a similar presentation and died in infancy. Based on the clinical and family history, which of the following congenital immunodeficiency disorders is most likely?</span></span></p>",
      "unique_key": "Q4966502",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198999,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A. Wiscott-Aldrich syndrome</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Explanation:</strong> The described features, including <strong><em>X-linked</em></strong> inheritance, <strong><em>thrombocytopenia</em></strong>, <strong><em>atopic dermatitis-like skin lesions</em></strong>, <strong><em>secondary bacterial skin</em></strong> infections, <strong><em>eczema herpeticum</em></strong>, <strong><em>molluscum contagiosum</em></strong>, and <strong><em>verruca plana</em></strong>, are characteristic of <strong>Wiscott-Aldrich syndrome (WAS)</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other options:</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>B. Ataxia telangiectasia:</strong> This disorder presents with <strong><em>progressive cerebellar ataxia</em></strong>, <strong><em>ocular and cutaneous telangiectasias</em></strong>, recurrent <strong><em>sinopulmonary infections</em></strong>, and an <strong><em>increased risk of malignancy</em></strong>. There is <strong>no predominant skin infection or thrombocytopenia.</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>C. Hyperimmunoglobulinemia E syndrome (Job syndrome):</strong> Patients have <strong><em>elevated IgE levels</em></strong>, <strong><em>recurrent skin and lung infections </em></strong>(often with <strong><em>Staphylococcus</em></strong> aureus), and <strong><em>skeletal</em></strong> and <strong><em>dental abnormalities</em></strong>. They <strong><em>do not</em></strong> present with <strong><em>thrombocytopenia or a history of X-linked inheritance</em></strong>.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>D. Chediak-Higashi syndrome:</strong> Characterized by <strong><em>albinism</em></strong>, recurrent <strong><em>pyogenic infections</em></strong>, and <strong><em>peripheral neuropathy</em></strong>. Patients have <strong><em>giant granules</em></strong> in leukocytes. There&#39;s no association with an atopic dermatitis-like rash or thrombocytopenia.</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therefore, the most fitting diagnosis for the presented case is <strong><em>WAS</em></strong>, an <strong><em>X-linked recessive disorder</em></strong>. <strong><em>Bone marrow transplantation</em></strong> is a potential curative treatment for affected individuals.</span></span></p>",
      "correct_choice_id": 103678,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25935,
      "choices": [
        {
          "id": 103686,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Multivessel high-grade stenoses</span></span></p>"
        },
        {
          "id": 103687,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ramus intermedius</span></span></p>"
        },
        {
          "id": 103688,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Severe mitral regurgitation</span></span></p>"
        },
        {
          "id": 103689,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Akinetic LV apex and mid-ventricular segments</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">A 63-year-old previously healthy woman with no significant medical history develops an abnormal EKG following the repair of a closed femur fracture sustained in a high-speed motor vehicle crash. The procedure was notable for mild tachycardia and hypotension but was otherwise uncomplicated. ECG shows 1-2 mm ST elevations in leads V2-V4 and deep T-wave inversions in V5, V6, and aVL. Serum troponin is 0.8. The patient undergoes an emergent coronary angiography, which reveals no evidence of acute thrombus formation. Which of the following additional findings is likely present?</span></span></span></p>",
      "unique_key": "Q2712440",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199001,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. D. Akinetic LV apex and mid-ventricular segments</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This patient demonstrates the classic presentation of stress-induced cardiomyopathy, also known as Takotsubo cardiomyopathy. This incompletely understood STEMI mimic typically follows severe emotional or physiological stress and may be due to an anatomic predisposition to ischemia in states of extreme catecholaminergic tone. The typical patient is a post-menopausal woman with ECG changes, including ST-elevations or pronounced T-wave inversions. Cardiac catheterization is required to make the diagnosis through an absence of significant coronary disease on angiography and akinesis of the LV apex (apical ballooning), typically overlapping a single vascular territory.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Incorrect Answers</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A. The diagnosis of Takotsubo is specifically in the absence of significant coronary lesions. Since this patient has no known risk factors, it is unlikely for her to have high-grade disease.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">B. Ramus intermedius is a normal coronary anatomic variant involving a trifurcation of the left main coronary artery, with the ramus intermedius arising between the LAD and left circumflex. It is present in roughly 20% of individuals.</span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Severe MR would not typically cause any of these major findings.</span></span></p>",
      "correct_choice_id": 103689,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25937,
      "choices": [
        {
          "id": 103694,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gabapentin</span></span></p>"
        },
        {
          "id": 103695,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amantadine</span></span></p>"
        },
        {
          "id": 103696,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Baclofen</span></span></p>"
        },
        {
          "id": 103697,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Interferon 1-beta</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">You are evaluating a 40-year-old woman in the neurology clinic who has been diagnosed with multiple sclerosis (MS) for the past five years. She recently started expressing feelings of sadness, hopelessness, and a loss of interest in activities she once enjoyed. She tearfully shares that she has never felt this way before. Upon reviewing her medication list, you identify several drugs used for managing her MS symptoms. Which of the following medications that she&#39;s taking could most likely be contributing to her newly developed depressive symptoms?</span></span></p>",
      "unique_key": "Q9835081",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199053,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. D. Interferon 1-beta</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Explanation:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Interferon 1-beta is a disease-modifying therapy used in the management of multiple sclerosis (MS). One of the recognized side effects of interferons, including Interferon 1-beta, is the development or exacerbation of depressive symptoms. When patients with MS on Interferon therapy present with new-onset depressive symptoms, it&#39;s crucial to consider the medication as a potential contributing factor. In such cases, monitoring the patient closely, collaborating with psychiatry, and potentially adjusting therapy may be warranted.</span></span></p>",
      "correct_choice_id": 103697,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25939,
      "choices": [
        {
          "id": 103702,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Ectopic Atrial Tachycardia</span></span></span></span></p>"
        },
        {
          "id": 103703,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Multifocal Atrial Tachycardia</span></span></span></span></p>"
        },
        {
          "id": 103704,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Sinus Tachycardia</span></span></span></span></p>"
        },
        {
          "id": 103705,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">AV nodal re-entrant tachycardia</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">An 84-year-old woman with a history of hypertension and spinal stenosis who was noted to have a sudden-onset tachycardia during preoperative evaluation. The patient received intravenous verapamil at which time she converted to normal sinus rhythm. Extended release verapamil was continued without further dysrhythmia recurrence.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-29-121250_AsrQHwT.jpg\" style=\"height:225px; width:400px\" /></span></span></span></span></p>",
      "unique_key": "Q2216498",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199105,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"background-color:white\"><span style=\"color:black\">Ans.</span></span></strong><strong> <span style=\"background-color:white\"><span style=\"color:black\">A. Ectopic Atrial Tachycardia</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Small P waves are seen immediately preceding each QRS complex. The P-wave axis is negative in the limb leads suggesting an ectopic atrial focus. This is immediately followed by a short PR interval and a narrow QRS complex. This represents Supraventricular Tachycardia (red arrows) Diffuse Non-Specific ST-T Changes (blue arrows) are present.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Most likely, this represents an ectopic atrial tachycardia originating low in the atrium in close proximity to the atrioventricular node. This would explain the negatively oriented P-wave axis and short PR interval as intra-atrial transit time to the atrioventricular node is shorter based on the abnormal origin of the atrial tachycardia focus.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-29-121251.jpg\" style=\"height:225px; width:400px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-29-121252.jpg\" style=\"height:224px; width:400px\" /></span></span></span></span></p>",
      "correct_choice_id": 103702,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25941,
      "choices": [
        {
          "id": 103710,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Prospective cohort study</span></span></p>"
        },
        {
          "id": 103711,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Retrospective cohort study</span></span></p>"
        },
        {
          "id": 103712,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Nested case control study</span></span></p>"
        },
        {
          "id": 103713,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Both (b) and (c)</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In which of the following study designs, the Outcome of interest has already taken place when the study is started?</span></span></p>",
      "unique_key": "Q6575692",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199197,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. Retrospective cohort study</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In a Prospective cohort study, Outcome has not yet occurred when the study has begun: Only exposure has occurred; we look for development of same disease in both exposed and non-exposed groups</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In a Retrospective cohort study, both exposure as well as outcome have occurred when the study has begun: First we go back in time and take only exposure into consideration (cohorts identified from past hospital/college records), then look for development of same disease in both exposed and non-exposed groups</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In a nested case control study, only exposure has occurred when the study begins; when the disease develops in a population later in time, then 2 groups of cases (diseased) and controls (non-diseased) are formed and their exposure status is compared.</span></span></li>\r\n</ul>",
      "correct_choice_id": 103711,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25944,
      "choices": [
        {
          "id": 103722,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">5 &alpha; reductase deficiency</span></span></p>"
        },
        {
          "id": 103723,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Complete Androgen Insensitivity Syndrome</span></span></p>"
        },
        {
          "id": 103724,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Reifenstein syndrome</span></span></p>"
        },
        {
          "id": 103725,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Swyer syndrome</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 15y girl is brought by her mother to the OPD. She says that her daughter has not yet attained menarche. She has been doing well in school and is on the school basketball team. However, her mother has noticed her voice has deepened and there is coarse hair growth on the chin since a few months. When you examine her, you find there is no breast development. There is sparse pubic and axillary hair and on local examination you find there is an enlarged clitoris. A karyotype done, reveals 46XY and an ultrasound reveals an absent uterus. Which is the most likely possibility?</span></span></p>",
      "unique_key": "Q3112347",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199260,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A. 5 &alpha; reductase deficiency</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This is most likely 5 &alpha; reductase deficiency </span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>There is failure of conversion of testosterone to 5DHT</strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Classical presentation:</strong></span></span></li>\r\n\t\t<li style=\"list-style-type:none\">\r\n\t\t<ul>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">External genitalia: predominantly female at birth; so usually reared as female. </span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Internal genitalia: Male (The epididymis, the vas deferens, seminal vesicles and ejaculatory ducts form but empty into a short blind vagina)</span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Testis: Located in the inguinal canal</span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">At Puberty: Virilization of varying degrees starts. </span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Affected patients:&nbsp; develop a normal muscle mass, libido, deepening of voice (Testosterone dependent) but have less body hair, less temporal hairline recession, no acne (All these are DHT dependent) </span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Suspect in adolescence with the characteristic phenotype and a serum hormonal profile showing normal male level testosterone and an increased testosterone/ DHT ratio)</span></span><br />\r\n\t\t\t&nbsp;</li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In Swyer syndrome</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This is a form of 46XY gonadal dysgenesis</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Both male and female internal genitalia are present</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">External genitalia is female</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Patients present as primary amenorrhoea with no secondary sexual characters</span></span><br />\r\n\t\t&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Complete Androgen Insensitivity syndrome</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This is a 46XY which presents as primary amenorrhoea with no internal or external male genitalia</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The external genitalia is female</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Pubic hair and axillary hair are absent</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Breast development is present due to peripheral conversion of androgens to estrogen</span></span><br />\r\n\t\t&nbsp;</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Reifenstein syndrome</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">46XY</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This is a milder form of androgen insensitivity syndrome</span></span></li>\r\n\t\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presents as ambiguous genitalia (under-virilized male) or as male infertility </span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>",
      "correct_choice_id": 103722,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25945,
      "choices": [
        {
          "id": 103726,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Increased PT</span></span></p>"
        },
        {
          "id": 103727,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Increased aPTT</span></span></p>"
        },
        {
          "id": 103728,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Decreased fibrinogen</span></span></p>"
        },
        {
          "id": 103729,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Increased FDPs</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which among the following laboratory investigation is best to reveal bleeding in Disseminated Intravascular Coagulation? </span></span></p>",
      "unique_key": "Q3843605",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199261,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. D. Increased FDPs</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The diagnosis of DIC is based on clinical observation and laboratory measurement of fibrinogen levels, platelets, the PT and PTT, and fibrin degradation products.</span></span></p>",
      "correct_choice_id": 103729,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25951,
      "choices": [
        {
          "id": 103750,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Sinus Bradycardia</span></span></span></span></p>"
        },
        {
          "id": 103751,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Complete Heart Block </span></span></span></span></p>"
        },
        {
          "id": 103752,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Mobitz Type II Block</span></span></span></span></p>"
        },
        {
          "id": 103753,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Wenckebach phenomenon</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">A 58-year-old female with exertional shortness of breath and forceful heart beating who sought medical attention and was discovered to have a loud systolic heart murmur with subsequent transthoracic echocardiography confirming a posterior leaflet mitral valve flail segment. This 12-lead electrocardiogram was obtained on her 2nd postoperative day following open-heart surgery in the form of mitral valve repair.</span></span> <span style=\"background-color:white\"><span style=\"color:black\">What is the likely diagnosis based on the ECG shown below?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-29-121253.jpg\" style=\"height:224px; width:400px\" /></span></span></span></span></p>",
      "unique_key": "Q3738362",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199337,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"background-color:white\"><span style=\"color:black\">Ans.</span></span> </strong><strong><span style=\"background-color:white\"><span style=\"color:black\">C. Mobitz Type II Block</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">P waves are readily identified with a normal P-wave axis at a regular atrial rate approximating 85 per minute reflecting Normal Sinus Rhythm (red arrows) Every other P wave conducts to the ventricle with a constant PR interval supporting atrioventricular association. The 2nd P wave in each sequence is followed by a nonconducted QRS complex supporting 2:1 Atrioventricular Conduction (blue arrows) &ndash; hence can be regarded as Mobitz 2 with 2:1 block</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-29-121254.jpg\" style=\"height:224px; width:400px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-29-121255.jpg\" style=\"height:224px; width:400px\" /></span></span></span></span></p>",
      "correct_choice_id": 103752,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25960,
      "choices": [
        {
          "id": 103786,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">p53</span></span></span></span></p>"
        },
        {
          "id": 103787,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">hMLH1</span></span></span></span></p>"
        },
        {
          "id": 103788,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">hMSH2</span></span></span></span></p>"
        },
        {
          "id": 103789,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">c-kit</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Which of the following mutations is associated with Crohn&rsquo;s disease related primary small bowel adenocarcinoma?</span></span></span></span></p>",
      "unique_key": "Q7857504",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199536,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"background-color:white\"><span style=\"color:black\">Ans.</span></span> </strong><strong><span style=\"background-color:white\"><span style=\"color:black\">A. p53</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">p53 mutations are associated with Crohn&rsquo;s disease-associated small bowel adenocarcinoma</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"background-color:white\"><span style=\"color:black\">Incorrect Answers:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">D - C-kit mutations are characteristic of GIST tumors.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">B and C. K-ras is associated with small bowel adenocarcinomas of the small bowel, while hMLH1 and hMSH2 are associated with Lynch-syndrome small bowel adenocarcinomas. The small bowel is often the first area to be affected by adenocarcinoma in up to 57% of patients with Lynch syndrome.</span></span></span></span></p>",
      "correct_choice_id": 103786,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25962,
      "choices": [
        {
          "id": 103794,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Shorter transit times through the small bowel</span></span></span></span></p>"
        },
        {
          "id": 103795,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Lower density of aerophilic gram-positive bacteria in the small bowel</span></span></span></span></p>"
        },
        {
          "id": 103796,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Lower concentration of gram-negative bacteria in the small bowel</span></span></span></span></p>"
        },
        {
          "id": 103797,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Higher concentration of microsomal enzymes in small bowel epithelia</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\">Although the small bowel accounts for 75% of the length and over 90% of the surface area of the gastrointestinal tract, small bowel neoplasms only account for approximately 3% of gastrointestinal cancers. Which of the following is not a possible protective mechanism in the small bowel that accounts for the relatively low rate of adenocarcinoma in the small bowel compared to the colon?</span></span></span></p>",
      "unique_key": "Q8520729",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199558,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"background-color:white\"><span style=\"color:black\">Ans.</span></span></strong> <strong><span style=\"background-color:white\"><span style=\"color:black\">C. Lower concentration of gram-negative bacteria in the small bowel</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Aerophilic gram-positive bacteria transform bile salts into deoxycholic acid, a tumor promoter. Overall, the small bowel has a much lower concentration of these bacteria than the colon. The ileum has the highest density of these organisms when compared to the duodenum and the jejunum. Thus far, the role of gram-negative bacteria, if any, in the pathogenesis of small bowel neoplasms is unknown. Microsomal enzymes, including benzopyrene hydroxylase, in the small bowel epithelia are thought to neutralize food-derived carcinogens and protect the small bowel from the development of cancer. Finally, the shorter transit time through the small bowel (compared to the large bowel) is thought to minimize contact time between the small bowel and potential carcinogens. </span></span></span></span></p>",
      "correct_choice_id": 103796,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25964,
      "choices": [
        {
          "id": 103802,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Hypomagnesemia</span></span></span></span></p>"
        },
        {
          "id": 103803,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Fanconi-like syndrome</span></span></span></span></p>"
        },
        {
          "id": 103804,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Renal salt wasting</span></span></span></span></p>"
        },
        {
          "id": 103805,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Thrombotic microangiopathy</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">A patient is treated with cisplatin and bleomycin and develops renal failure. Which of the following is a characteristic of renal failure that may occur specifically when cisplatin is given with bleomycin?</span></span></span></span></p>",
      "unique_key": "Q5587760",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199560,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"background-color:white\"><span style=\"color:black\">Ans.</span></span> </strong><strong><span style=\"background-color:white\"><span style=\"color:black\">D. Thrombotic microangiopathy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">When cisplatin is administered with bleomycin, it may be associated with thrombotic microangiopathy with features of the hemolytic-uremic syndrome or thrombotic thrombocytopenic purpura, presumably reflecting direct vascular injury and secondary platelet activation. This has also been reported with gemcitabine and cisplatin combination therapy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Cisplatin-associated renal tubular dysfunction and cumulative renal impairment can limit the dose of cisplatin. Multiple mechanisms contribute to renal dysfunction as a result of cisplatin toxicity, including tubular epithelial cell toxicity, vasoconstriction in the renal microvasculature, and pro-inflammatory effects. The proximal tubules are selectively injured by cisplatin. The nephrotoxicity of cisplatin is possibly the result of enhanced renal uptake of cisplatin by organic transporters, followed by reduced expression and function of sodium-dependent glucose and amino-acid transporters, reduced expression and function of magnesium and water transporters, metabolism of cisplatin to glutathione and conjugates of cysteinyl-glycine, and generation of reactive oxygen species.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Renal impairment varies in incidence depending up the dose and frequency of drug administration but has been seen in more than 50% of cases in some trials. Incidence and severity increase with subsequent courses and can become irreversible over time, so the progression of renal impairment is an indication for discontinuation of therapy. Higher doses for bone marrow transplantation cannot be used due to severe toxicity, so carboplatin, which is a less toxic analog, may be used in that setting. In most cases, urine output in patients with nephrotoxicity remains above 1000 mL per day unless the renal failure is advanced. This is due to the induction of a concentrating defect, possibly as a result of platinum-induced damage to the loop of Henle. Hypomagnesemia occurs in over 50% of cases of cisplatin-induced nephrotoxicity due to urinary magnesium wasting. Resultant hypomagnesemia may exacerbate toxicity of cisplatin. Fanconi-like syndrome accompanies cisplatin-mediated nephrotoxicity, although classic Fanconi syndrome has not been reported. Renal salt wasting is a rare manifestation of cisplatin nephrotoxicity that has been described in some small series and cases.</span></span></span></span></p>",
      "correct_choice_id": 103805,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25966,
      "choices": [
        {
          "id": 103810,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Alkylating agents</span></span></span></span></p>"
        },
        {
          "id": 103811,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Corticosteroids</span></span></span></span></p>"
        },
        {
          "id": 103812,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Antimetabolites</span></span></span></span></p>"
        },
        {
          "id": 103813,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Plant alkaloids</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">A 23-year-old man with HL was treated successfully with the ABVD regimen. Which of the following drugs used in the treatment of this patient is cell cycle specific?</span></span></span></span></p>",
      "unique_key": "Q6997868",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199652,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"background-color:white\"><span style=\"color:black\">Ans.</span></span></strong> <strong><span style=\"background-color:white\"><span style=\"color:black\">D. Plant alkaloids</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Although all the drugs mentioned in the options (except alkylating agents) are cell cycle specific &ndash; the treatment regime is ABVD. In the regime Bleomycin (antitumor antibiotic &ndash; G2 specific) and Vinblastine (vinca alkaloid- M specific) are cell cycle specific drugs. Adriamycin (antitumor antibiotic) and Dacarbazine (alkylating agent) is not cell cycle specific.&nbsp;</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">In the options Corticosteroids (G1 specific) and antimetabolites (S specific) are cell cycle specific drugs but they are not a part of ABVD regime</span></span></span></span></p>",
      "correct_choice_id": 103813,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25968,
      "choices": [
        {
          "id": 103818,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Female sex</span></span></p>"
        },
        {
          "id": 103819,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Breech position</span></span></p>"
        },
        {
          "id": 103820,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Positive family history</span></span></p>"
        },
        {
          "id": 103821,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Gestational diabetes</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Which is the least important risk factor associated with developmental dysplasia of the hip? </span></span></p>",
      "unique_key": "Q3945311",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199674,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. D. Gestational diabetes</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The two most important risk factors for developmental dysplasia of the hip are a positive family history and breech position. The other important risk factors are first born children and female sex. Gestational diabetes is not particularly associated with developmental dysplasia of the hip.</span></span></p>",
      "correct_choice_id": 103821,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25970,
      "choices": [
        {
          "id": 103826,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Anion gap metabolic acidosis with mixed respiratory alkalosis</span></span></span></span></p>"
        },
        {
          "id": 103827,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Anion gap metabolic acidosis plus metabolic alkalosis</span></span></span></span></p>"
        },
        {
          "id": 103828,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Anion gap metabolic acidosis plus normal anion gap metabolic acidosis</span></span></span></span></p>"
        },
        {
          "id": 103829,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Anion gap metabolic acidosis with mixed respiratory acidosis</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">A patient has the following laboratory findings:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-30-112141.jpg\" style=\"height:348px; width:700px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Which of the following is the most likely acid-base status?</span></span></span></span></p>",
      "unique_key": "Q7377252",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199699,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"background-color:white\"><span style=\"color:black\">Ans.</span></span> </strong><strong><span style=\"background-color:white\"><span style=\"color:black\">B. Anion gap metabolic acidosis plus metabolic alkalosis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">The most likely acid-base status is anion gap metabolic acidosis plus metabolic alkalosis. The patient has metabolic acidosis, as shown by the low pH and decreased serum bicarbonate values. The anion gap, which is normally 8 to 10 mEq/L &plusmn; 2 mEq/L (8-10 mmol/L &plusmn; 2.0 mmol/L), is calculated by the following formula: sodium &minus; (chloride + bicarbonate). In this patient, the anion gap is 40 mEq/L (40 mmol/L), which is significantly elevated. One can then determine what the serum bicarbonate level would have been if the patient did not have an anion gap metabolic acidosis by adding back the increase (from normal) in anion gap (in this instance, 28 mEq/L [28 mmol/L] [that is, 40 &ndash; 12]) to the patient&#39;s current serum bicarbonate level. Adding 28 mEq/L (28 mmol/L) to 12 mEq/L (12 mmol/L) equals 40 mEq/L (40 mmol/L), which means that the bicarbonate level would have been elevated at 40 mEq/L (40 mmol/L) if the patient did not have anion gap metabolic acidosis. This result indicates superimposed metabolic alkalosis. Whenever the anion gap exceeds 30 mEq/L, concurrent metabolic alkalosis is almost always present.</span></span></span></span></p>",
      "correct_choice_id": 103827,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25972,
      "choices": [
        {
          "id": 103834,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gardner syndrome</span></span></p>"
        },
        {
          "id": 103835,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peutz-Jeghers syndrome</span></span></p>"
        },
        {
          "id": 103836,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cowden syndrome</span></span></p>"
        },
        {
          "id": 103837,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dyskeratosis congenita</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old female presents to the clinic with complaints of recurrent anemia and occasional gastrointestinal bleeding. On examination, numerous lentigines are observed on her mucous membranes as shown in the image below, digits, palms, and soles. Further evaluation reveals multiple hamartomatous polyps in her gastrointestinal tract. Her family history is notable for her mother having ovarian cancer and her aunt with breast cancer. Based on her presentation and family history, which of the following syndromes is she most likely to have, which is also associated with an increased incidence of gastric carcinoma?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/whatsapp-image-2023-09-30-at-174209.jpeg\" style=\"height:200px; width:300px\" /></span></span></p>",
      "unique_key": "Q5750933",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199751,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. Peutz-Jeghers syndrome</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Explanation:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The patient&#39;s presentation is indicative of Peutz-Jeghers syndrome, which is caused by a mutation in the tumor suppressor gene STK11.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Key features of Peutz-Jeghers syndrome include:</span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lentigines on the mucous membranes, digits, palms, and soles.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Increased incidence of hamartomatous polyps in the gastrointestinal tract, which can lead to symptoms like gastrointestinal bleeding.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Although only 2-3% of these polyps may turn malignant, the most common sites of malignancy are the stomach and small intestine.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Apart from gastric carcinoma, patients also have an increased risk of developing ovarian, breast, and pancreatic cancer.</span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Other options</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A) Gardner syndrome is primarily associated with malignant adenocarcinoma of the colon and rectum.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">C) Cowden syndrome: Mutations in the PTEN gene are responsible for the majority of cases. It is linked with follicular thyroid carcinoma, breast cancer, and endometrial cancer.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">D) Dyskeratosis congenita: Triad of nail dystrophy, lacy reticular pigmentation on the neck and upper chest, and oral leucoplakia. It is associated with mucosal squamous cell carcinoma, bone marrow failure, acute myeloid leukaemia, and Hodgkin disease.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Given the patient&#39;s clinical features and family history, Peutz-Jeghers syndrome is the most likely diagnosis, and it is also associated with an increased risk of gastric carcinoma.</span></span></p>",
      "correct_choice_id": 103835,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25973,
      "choices": [
        {
          "id": 103838,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ask-Up mark kidney</span></span></p>"
        },
        {
          "id": 103839,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Wunderlich phenomenon</span></span></p>"
        },
        {
          "id": 103840,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Page kidney</span></span></p>"
        },
        {
          "id": 103841,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Renal infarct</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old male presents to the emergency department following a recent road traffic accident. He was involved in a high-speed collision and sustained blunt trauma to his abdomen and lower back. He complains of severe left-sided flank pain and haematuria. This was managed conservatively in view of AAST Grade 2 injury on CECT. During his in-patient stay, it was noticed that his BP is increasing while he was previously normotensive. His Baseline CECT is shown here. What is the likely explanation for his course? </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-30-112143.jpg\" style=\"height:233px; width:300px\" /></span></span></p>",
      "unique_key": "Q5447903",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199752,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. Page kidney</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Page kidney is a medical condition characterized by the compression or external pressure on the kidney, often caused by the accumulation of fluid or blood in the space surrounding the kidney, known as the perinephric space. This external pressure can lead to decreased blood flow to the kidney and, consequently, impaired kidney function.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The most common cause of Page kidney is the accumulation of blood in the perinephric space following a traumatic injury. However, Page kidney can also occur due to other conditions, such as: Renal artery stenosis, Renal tumors or cysts or Infections. </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Symptoms of Page kidney may include: Flank pain, Hypertension, Decreased urine output or Kidney dysfunction or failure</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Treatment of Page kidney often involves addressing the underlying cause of external compression. </span></span></p>",
      "correct_choice_id": 103840,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25975,
      "choices": [
        {
          "id": 103846,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1a, 2b, 3d, 4c</span></span></p>"
        },
        {
          "id": 103847,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1b, 2a, 3d, 4c</span></span></p>"
        },
        {
          "id": 103848,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1c, 2a, 3d, 4b</span></span></p>"
        },
        {
          "id": 103849,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1b, 2c, 3c, 4d</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In each scenario, choose the best plan for management:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-30-112144.jpg\" style=\"height:437px; width:700px\" /></span></span></p>",
      "unique_key": "Q4365786",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199774,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. 1b, 2a, 3d, 4c</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Scenario 1 is Intrahepatic cholestasis of pregnancy; Treatment is Induction of labor as she has crossed 37 weeks</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Scenario 2 is most likely viral hepatitis; treatment is conservative management</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Scenario 3 is HELLP syndrome, treatment is MgSO4 and cesarean is preferred as there is severe FGR with reversal of diastolic flow</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Scenario 4 is likely Acute Fatty Liver of Pregnancy, Treatment is immediate delivery, here emergency LSCS is preferred as there is severe oligohydramnios</span></span></li>\r\n</ul>",
      "correct_choice_id": 103847,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25977,
      "choices": [
        {
          "id": 103854,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1,2,3,4</span></span></p>"
        },
        {
          "id": 103855,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">2,3,4,1 </span></span></p>"
        },
        {
          "id": 103856,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1,3,4,2</span></span></p>"
        },
        {
          "id": 103857,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1,4,2,3</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Organize the listed bands within the sarcomere, starting from the periphery and moving towards the center.</span></span></p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Z line</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">M line</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A band</span></span></li>\r\n\t<li><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">H zone</span></span></li>\r\n</ol>",
      "unique_key": "Q1722646",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199937,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. 1,3,4,2</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The proper order of bands within the sarcomere, moving from the periphery towards the center, is as follows: Z line - I band - A band - H zone - M line.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-30-112145.jpg\" style=\"height:317px; width:700px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Z line</strong>: A dense protein structure that separates one sarcomere from the next and serves as an anchor for actin filaments.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>I band</strong>: The light-colored region in a sarcomere composed of only thin actin filaments.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>A band</strong>: The dark-colored region in a sarcomere containing both thick myosin and thin actin filaments.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>H zone</strong>: The central part of the A band where only thick myosin filaments are present.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>M line</strong>: The center of the sarcomere, providing structural support and anchoring the myosin filaments.</span></span></p>",
      "correct_choice_id": 103856,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25979,
      "choices": [
        {
          "id": 103862,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aberrant connection between the bladder and vagina</span></span></p>"
        },
        {
          "id": 103863,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diminished contractility of the bladder detrusor </span></span></p>"
        },
        {
          "id": 103864,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Excessive involuntary detrusor muscle spasms</span></span></p>"
        },
        {
          "id": 103865,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">External compression of the urethral outlet </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 49-year-old woman, gravida 5 para 5, comes to the office due to urine leakage. Over the last 2 months, the patient has had constant urinary leaking, requiring her to wear a pad day and night. She has no dysuria, urgency, or vulvar pruritis. The patient has type 2 diabetes mellitus that is well controlled with oral medication. Two years ago, she received brachytherapy and external-beam pelvic radiation for cervical cancer.&nbsp; BMI is 43 kg/m. Pelvic examination shows no urethral leakage with Valsalva. There are post radiation changes and a pool of clear fluid in the vagina. Postvoid residual volume is 20 mL. Urinalysis results from catheterization are as follows:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Specific gravity-1.004</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Blood-trace</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Glucose-negative</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Leukocyte esterase negative</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Nitrites-negative</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Bacteria-few</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">White blood cells- 1-2/hpf</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Which of the following is the most likely cause of this patient&#39;s symptoms?</span></span></p>",
      "unique_key": "Q4093360",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199959,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>A. Aberrant connection between the bladder and vagina</strong></span></span></p>",
      "correct_choice_id": 103862,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25981,
      "choices": [
        {
          "id": 103870,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1- A, 2-D, 3-H, 4-C</span></span></p>"
        },
        {
          "id": 103871,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1-B, 2-G, 3-H, 4-F</span></span></p>"
        },
        {
          "id": 103872,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1-E, 2-D, 3-H, 4-G</span></span></p>"
        },
        {
          "id": 103873,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1- A, 2-G, 3-H, 4-C</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following X-rays with the correct cause of respiratory distress: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-30-112146_NvhptB2.jpg\" style=\"height:662px; width:700px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>",
      "unique_key": "Q9539824",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199981,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>B. 1-B, 2-G, 3-H, 4-F</strong></span></span></p>",
      "correct_choice_id": 103871,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25982,
      "choices": [
        {
          "id": 103874,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Plan for urgent surgical exploration</span></span></p>"
        },
        {
          "id": 103875,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Air enema</span></span></p>"
        },
        {
          "id": 103876,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">CT scan </span></span></p>"
        },
        {
          "id": 103877,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">MRI </span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 8-month-old child after vaccination presents to the emergency with incessant crying and legs drawn up. X-ray abdomen showed signs of free air. USG is done next which shows the following. What will you do next?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-30-112147.jpg\" style=\"height:378px; width:400px\" /></span></span></p>",
      "unique_key": "Q2525745",
      "question_audio": null,
      "question_video": null,
      "map_id": 1200002,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>A. Plan for urgent surgical exploration</strong></span></span></p>",
      "correct_choice_id": 103874,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25985,
      "choices": [
        {
          "id": 103886,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Inferior thyroid artery</span></span></p>"
        },
        {
          "id": 103887,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Transverse cervical artery</span></span></p>"
        },
        {
          "id": 103888,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Thyrocervical trunk</span></span></p>"
        },
        {
          "id": 103889,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Costocervical trunk</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During surgery on a 56-year-old man for a squamous cell carcinoma of the neck, the surgeon notices profuse bleeding from the deep cervical artery. Which of the following arteries must be ligated immediately to stop bleeding?</span></span></p>",
      "unique_key": "Q5523261",
      "question_audio": null,
      "question_video": null,
      "map_id": 1200025,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>D. Costocervical trunk</strong></span></span></p>",
      "correct_choice_id": 103889,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25986,
      "choices": [
        {
          "id": 103890,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">3, 1, 4, 2</span></span></p>"
        },
        {
          "id": 103891,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">2, 4, 1, 3</span></span></p>"
        },
        {
          "id": 103892,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1, 2, 3, 4</span></span></p>"
        },
        {
          "id": 103893,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4, 3, 2, 1</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Organize the subsequent afferent columns in the floor of the fourth ventricle, proceeding from the medial to the lateral direction.</span></span></p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">General somatic</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">General visceral</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Special somatic</span></span></li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Special visceral</span></span></li>\r\n</ol>",
      "unique_key": "Q6959005",
      "question_audio": null,
      "question_video": null,
      "map_id": 1200026,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>B. 2, 4, 1, 3</strong></span></span></p>",
      "correct_choice_id": 103891,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25988,
      "choices": [
        {
          "id": 103898,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartonella henselae</span></span></p>"
        },
        {
          "id": 103899,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Human herpesvirus 8 (HHV-8) </span></span></p>"
        },
        {
          "id": 103900,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lichen planus </span></span></p>"
        },
        {
          "id": 103901,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Psoriasis</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">44-year-old man comes to the clinic for evaluation of a &quot;mole.&quot; He has a slowly enlarging macule that was first noticed by his partner 6 weeks ago. The lesion has no associated pain or itching, but it has changed in colour from pink to violet. On review of systems, he denies fever, night sweats, or urinary symptoms. The patient reports an unintentional weight loss of approximately 8 kg over the past year. He was treated for syphilis 2 years ago with long-acting penicillin. He had multiple male sexual partners in the last 20 years and works as a freelance website developer. He does not use tobacco or illicit drugs but drinks alcohol heavily on weekends. Temperature is 37.1 C (98.8 F), blood pressure is 115/70 mm Hg, pulse is 80/min, and respirations are 14/min. The skin lesion is shown in the image below. Which of the following is the most likely cause of this patient&#39;s skin lesion?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-30-112150.jpg\" style=\"height:241px; width:300px\" /></span></span></p>",
      "unique_key": "Q6297019",
      "question_audio": null,
      "question_video": null,
      "map_id": 1200098,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>B. Human herpesvirus 8 (HHV-8)</strong></span></span></p>",
      "correct_choice_id": 103899,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25924,
      "choices": [
        {
          "id": 103642,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Pectoralis Major Myo-cutaneous flap - Acromio-thoracic artery</span></span></p>"
        },
        {
          "id": 103643,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Antero-lateral Thigh flap - Medial circumflex femoral</span></span></p>"
        },
        {
          "id": 103644,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Free fibular flap - Peroneal artery</span></span></p>"
        },
        {
          "id": 103645,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Rectus abdominal - Deep inferior epigastric artery</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Identify the mismatch vascular anatomy in flap reconstructions in plastic surgery:</span></span></p>",
      "unique_key": "Q9183414",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198901,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. </strong><strong>Antero-lateral Thigh flap- medial circumflex femoral</strong></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Pedicled:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">PMMC- acromiothoracic</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Delto-pectoral flap- Internal mammary</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">TRAM- superficial/deep inferior epigastric</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Free:</span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Radial free forearm/Composite arm- radial artery</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Free fibular flap- peroneal</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Antero-lateral thigh- <strong>lateral&nbsp;</strong>circumflex femoral</span></span></li>\r\n</ul>",
      "correct_choice_id": 103643,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25930,
      "choices": [
        {
          "id": 103666,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Positive rheumatoid factor</span></span></p>"
        },
        {
          "id": 103667,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Mouse ear sign on X-ray</span></span></p>"
        },
        {
          "id": 103668,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Bilateral symmetric disease</span></span></p>"
        },
        {
          "id": 103669,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Involvement of only the proximal interphalangeal joints of a digit</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Which of the following findings suggest a diagnosis of psoriatic arthritis in a patient with psoriasis, dactylitis, and tenderness in the sacroiliac joints?</span></span></p>",
      "unique_key": "Q6813563",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198907,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. Mouse ear sign on X-ray</strong></span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Psoriatic arthritis is a seronegative spondylarthropathy that predominantly affects the DIP joints in the hand and feet. One or more joints are affected and will be warm, tender, and erythematous. Asymmetrical oligoarthritis is the most common presentation. The radiological signs associated with psoriatic arthritis include bilateral asymmetrical disease with involvement of distal interphalangeal joints, enthesitis, bone proliferation, and preserved bone density. The &ldquo;mouse ear&rdquo; sign refers to erosions with new bone formation, which consists of fluffy periostitis. The &ldquo;ray sign&rdquo; is another characteristic finding that refers to involvement of all joints in one digit. Dactylitis results in sausage digits. Skin lesions usually precede arthritis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Incorrect Answers:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A. Rheumatoid factor is negative in the seronegative sponylarthropathies.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">C. Symmetric disease occurs in only 15% of patients.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">D. Involvement of the distal interphalangeal joints is characteristic.</span></span></p>",
      "correct_choice_id": 103667,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25932,
      "choices": [
        {
          "id": 103674,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Goitre is retrosternal</span></span></p>"
        },
        {
          "id": 103675,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Malignant transformation</span></span></p>"
        },
        {
          "id": 103676,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Post operative airway risk</span></span></p>"
        },
        {
          "id": 103677,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Infiltration of carotid artery</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 60-year-old male with history of long standing goitre visits the OPD. Surgeon performs this manoeuver- which makes the patient breathless. This finding implies?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-29-121249.jpg\" style=\"height:204px; width:300px\" /></span></span></p>",
      "unique_key": "Q2554494",
      "question_audio": null,
      "question_video": null,
      "map_id": 1198978,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. Post operative airway risk</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The shown test is Kocher&rsquo;s test, which implies trachea-malacia or scabbard trachea. This occurs on giving compression to goitre and patient experiencing breathlessness/stridor. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In patients with Scabbard trachea/Kocher&rsquo;s test positive- post operative airway collapse is anticipated and tracheostomy may be required.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Retrosternal goitre- Pemberton sign</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Infiltration of carotid artery- Berry&rsquo;s sign</span></span></p>",
      "correct_choice_id": 103676,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25934,
      "choices": [
        {
          "id": 103682,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Methotrexate</span></span></p>"
        },
        {
          "id": 103683,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oral prednisone</span></span></p>"
        },
        {
          "id": 103684,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Infliximab</span></span></p>"
        },
        {
          "id": 103685,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Mesalamine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A patient is diagnosed with moderate psoriatic arthritis resistant to NSAIDs. Which of the following is recommended as first line therapy to prevent joint destruction?</span></span></p>",
      "unique_key": "Q9721558",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199000,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. Infliximab</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Psoriatic arthritis is a seronegative spondylarthritis characterized by asymmetric oligoarthritis or symmetric polyarthritis. Skin changes typically precede arthritis. They include scaly silver plaques on the extensor surfaces of the forearm and lower extremity. Five to ten percent of patients with psoriasis are affected by psoriatic arthritis. The American College of Rheumatology/National Psoriasis Foundation currently recommend treatment with TNF-alpha inhibitors for treatment naive patients with active PSA. These guidelines recommend oral small molecules such as methotrexate if patients do not have severe PSA and either have contraindications to TNF-inhibitor therapy or are concerned about initiating treatment with a biologic as a first line therapy. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Incorrect Answers:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A. Methotrexate is an oral small molecule which can be used in treating PSA.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">B. When glucocorticoids are used, they are applied topically or injected locally.</span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">D. Mesalamine is the active metabolite of sulfasalazine. It is not used in treatment of psoriatic arthritis.</span></span></p>",
      "correct_choice_id": 103684,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25942,
      "choices": [
        {
          "id": 103714,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Immune thrombocytopenia</span></span></p>"
        },
        {
          "id": 103715,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Protein C deficiency</span></span></p>"
        },
        {
          "id": 103716,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Fibrinogen deficiency </span></span></p>"
        },
        {
          "id": 103717,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Von Willebrand disease</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 28-year-old woman presents to the emergency department with excessive bleeding following a tooth extraction. She has a family history of bleeding disorders. Laboratory tests show a normal platelet count and coagulation factor levels. Thromboelastography (TEG) is performed and reveals a normal R-time but a significantly decreased &alpha;-angle as well as reduced maximum amplitude (MA). What is the most likely explanation for these TEG findings?</span></span></p>",
      "unique_key": "Q5167351",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199218,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. D. Von Willebrand disease</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In this patient with a family history of bleeding disorders and TEG findings of a decreased &alpha;-angle and MA, the most likely explanation is von Willebrand disease (VWD). VWD is characterized by a deficiency or dysfunction of von Willebrand factor (VWF), which impairs platelet adhesion and aggregation. TEG can reveal reduced clot strength (MA) and a decreased &alpha;-angle due to impaired platelet function.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Option a, Immune thrombocytopenia is associated with reduced platelet count. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Option b, Protein C deficiency causes Hypercoagulability which would typically result in a TEG pattern with increased clot strength.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Option c, fibrinogen deficiency, may lead to a prolonged R-time and decreased MA but would not explain the normal R-time seen in this case.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/whatsapp-image-2023-09-30-at-110901.jpeg\" style=\"height:926px; width:1000px\" /></span></span></p>",
      "correct_choice_id": 103717,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25947,
      "choices": [
        {
          "id": 103734,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Pyroptosis</span></span></p>"
        },
        {
          "id": 103735,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Necroptosis</span></span></p>"
        },
        {
          "id": 103736,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Autophagy</span></span></p>"
        },
        {
          "id": 103737,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ferroptosis</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old female with a history of rheumatoid arthritis presents with joint pain and swelling. Laboratory investigations reveal elevated levels of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF). Imaging studies show erosions and deformities in the joints. Further investigation reveals activation of caspase-4 and release of IL-1&beta; and IL-18 in the synovial fluid. Which of the following forms of regulated cell death is likely contributing to the joint inflammation and damage in this patient?</span></span></p>",
      "unique_key": "Q3374922",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199263,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A. Pyroptosis</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The clinical history of rheumatoid arthritis and joint inflammation and damage, along with activation of caspase-4 and release of IL-1&beta; and IL-18 in the synovial fluid, suggests the involvement of pyroptosis. Pyroptosis has been implicated in the pathogenesis of rheumatoid arthritis, where activation of caspase-4 and release of IL-1&beta; and IL-18 contribute to the joint inflammation and damage observed in this patient. </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Necroptosis (option B) is a form of regulated cell death that occurs in response to various stimuli, including inflammation, but is not typically associated with the release of proinflammatory cytokines. Autophagy (option C) is a cellular process involved in degradation and recycling of cellular components and may have both pro-survival and pro-death functions in rheumatoid arthritis. Ferroptosis (option D) is a distinct form of regulated cell death characterized by iron-dependent lipid peroxidation and is not directly associated with the clinical scenario described.</span></span></li>\r\n</ul>",
      "correct_choice_id": 103734,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25949,
      "choices": [
        {
          "id": 103742,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">1 hour</span></span></span></span></p>"
        },
        {
          "id": 103743,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">2 hours</span></span></span></span></p>"
        },
        {
          "id": 103744,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">1 day</span></span></span></span></p>"
        },
        {
          "id": 103745,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">12 hours</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70 Kg person was started on a drug with Vd =10 L and exhibits first-order elimination kinetics.&nbsp; The rate of drug clearance is calculated to be 6.93 L/hr.&nbsp; It is determined that repeating the second dose when 75% of the drug is eliminated will minimize toxicity while maintaining trough levels above the minimum inhibitory concentration.&nbsp; Based on these research findings, which of the following is the most appropriate dosing interval for this drug?</span></span></span></span></p>",
      "unique_key": "Q2051464",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199285,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans B. 2 hours</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To determine the dosing interval for this drug, we need to first calculate the half-life (t1/2) of the drug. We can use the formula:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t1/2 = 0.693 x Vd / clearance</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">where Vd is the volume of distribution and clearance is the rate of drug clearance.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Substituting the given values, we get:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t1/2 = 0.693 x 10 / 6.93 t1/2 = 1 hour </span></span></span></span></p>\r\n\r\n<p style=\"margin-left:19px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The time to eliminate 75% of the drug would be 2 half-lives (in 1 half-life 50 percent is eliminated and in 2 half-lives 75 percent will be eliminated). Therefore, the time to eliminate 75% of the drug would be:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t = 2 x t1/2 = 2.5 x 1.00 = 2 hours</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So, the appropriate dosing interval would be around 2 hours to ensure that 75% of the previous dose is eliminated before the next dose is given. </span></span></span></span></p>",
      "correct_choice_id": 103743,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25953,
      "choices": [
        {
          "id": 103758,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Femorofemoral bypass</span></span></p>"
        },
        {
          "id": 103759,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Axillofemoral bypass </span></span></p>"
        },
        {
          "id": 103760,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Aortobifemoral bypass</span></span></p>"
        },
        {
          "id": 103761,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Common femoral and profunda femoral endarterectomies</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 72-year-old woman with severe COPD who requires home oxygen is unable to ambulate inside her home without experiencing severe left hip pain. She was hospitalized 1 year ago for a viral pneumonia and was ventilator-dependent at that time for 6 weeks. On examination, her blood pressure is 165/80 mm Hg. She has weakly palpable bilateral femoral pulses. An angiogram demonstrates severe aorto-iliac disease involving bilateral iliac vessels. Which of the following is the most appropriate vascular procedure for this patient?</span></span></p>",
      "unique_key": "Q1895358",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199339,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. Axillofemoral bypass</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">An axillofemoral graft is tunnelled subcutaneously between the axillary artery proximally to reach one or both of the femoral arteries; the patency rates of an axillobifemoral bypass are better than those for an axillo(uni)femoral bypass.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Aortobifemoral bypass carries a perioperative mortality and systemic morbidity (stroke, cardiorespiratory failure, renal injury) rate of about 5% and 15%, respectively. <strong>In unfit patients, an axillobifemoral bypass is an alternative, although patency rates are less.</strong></span></span></p>",
      "correct_choice_id": 103759,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25955,
      "choices": [
        {
          "id": 103766,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pseudoparalysis of Parrot</span></span></p>"
        },
        {
          "id": 103767,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Higoumenakis sign</span></span></p>"
        },
        {
          "id": 103768,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Generalized paresis</span></span></p>"
        },
        {
          "id": 103769,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Saber shins</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 15-month-old infant is brought to the clinic by her concerned parents who report that she is not using her left arm. She had been in good health until recently when she developed a non-productive cough and a persistently runny nose. On physical examination, the infant is found to have a runny nose with purulent discharge, moist rales in the chest, a generalized rash, and hepatosplenomegaly. Additionally, a mucocutaneous rash is noted on the palms and soles. There&#39;s also evidence of painful movement and swelling of the left upper arm, suggestive of osteochondritis. Which of the following is most consistent with this infant&#39;s presentation in the context of early congenital syphilis?</span></span></p>",
      "unique_key": "Q2990516",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199461,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A. Pseudoparalysis of Parrot</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Explanation:</strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This infant&#39;s presentation is characteristic of&nbsp;<strong>Early Congenital Syphilis</strong>. Among the options provided:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A)&nbsp;<strong>Pseudoparalysis of Parrot&nbsp;</strong>is seen in early congenital syphilis in children less than two years old. This pseudoparalysis results from&nbsp;<strong><em>painful osteochondritis</em></strong>, which leads the infant to&nbsp;<strong><em>avoid moving the affected limb</em></strong>. The presence of symptoms such as a <strong><em>runny nose</em></strong> with purulent discharge (<strong><em>rhinitis/snuffles</em></strong>), generalized rash, <strong><em>hepatosplenomegaly</em></strong>, and the described pseudoparalysis are consistent with&nbsp;<strong><em>early congenital syphilis.</em></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other options:</strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">B)&nbsp;<strong>Higoumenakis sign&nbsp;</strong>is characteristic of late congenital syphilis and presents as a unilateral hyperostosis of the inner third of the clavicle.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">C)&nbsp;<strong>Generalized paresis of Insane&nbsp;</strong>is a neurologic manifestation seen in tertiary syphilis, not early congenital syphilis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">D)&nbsp;<strong>Saber shins&nbsp;</strong>are a deformity of the anterior tibia seen in late congenital syphilis, as shown in the image below.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-29-121256.jpg\" style=\"height:264px; width:400px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hence, based on the infant&#39;s clinical presentation and age, Pseudoparalysis of Parrot due to osteochondritis is the most consistent finding with early congenital syphilis.</span></span></p>",
      "correct_choice_id": 103766,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25957,
      "choices": [
        {
          "id": 103774,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It is called AMBU bag</span></span></p>"
        },
        {
          "id": 103775,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It nearly gives 100% oxygen</span></span></p>"
        },
        {
          "id": 103776,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It is also called bag valve mask</span></span></p>"
        },
        {
          "id": 103777,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It is used in only spontaneously breathing patients</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">I</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">n a dramatic and action-packed South Indian film, superstar Rajnikanth finds himself in a critical situation where a sudden calamity has left several people unconscious and struggling to breathe. With his quick thinking and vast knowledge, Rajnikanth immediately grabs the device given below, from a nearby medical kit. He swiftly moves from patient to patient, using the manual resuscitator to deliver oxygen and successfully reviving each individual.</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> All true about apparatus in picture except? </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-29-121257.jpg\" style=\"height:300px; width:300px\" /></span></span></p>",
      "unique_key": "Q4975032",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199513,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. D. It is used in only spontaneously breathing patients</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A bag valve mask, abbreviated to BVM and sometimes known by the&nbsp;&nbsp; proprietary name&nbsp;&nbsp; AMBU bag or generically as a manual resuscitator self-inflating bag is a hand-held device commonly used to provide positive pressure ventilation&nbsp;&nbsp; to patients who are not breathing or not breathing adequately. The device is a required part of resuscitation kits for trained professionals in out-of- hospital settings (such as ambulance crews) and is also frequently used in&nbsp;&nbsp;&nbsp; hospitals&nbsp;&nbsp;&nbsp; as part of standard equipment found on crash cart, in emergency rooms or other critical care settings. Underscoring the frequency and prominence of BVM use in the United States, the American Heart Association (AHA) Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiac Care recommend that &ldquo;all healthcare providers should be familiar with the use of the bag-mask device.&rdquo;&nbsp; Manual resuscitators are also used within the hospital for temporary ventilation of patients dependent on&nbsp;&nbsp; mechanical ventilators&nbsp;&nbsp; when the mechanical ventilator needs to be examined for possible malfunction, or when ventilator-dependent patients are transported within the hospital. Two principal types of manual resuscitators exist; one version is self-filling with&nbsp;&nbsp; air, although additional&nbsp;&nbsp; oxygen (O2) can be added but is not necessary for the device to function. The other principal type of manual resuscitator (flow-inflation) is heavily used in non- emergency applications in the operating room to ventilate patients during anesthesia induction.</span></span></p>",
      "correct_choice_id": 103777,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25958,
      "choices": [
        {
          "id": 103778,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">D-penicillamine</span></span></span></span></p>"
        },
        {
          "id": 103779,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Trientine</span></span></span></span></p>"
        },
        {
          "id": 103780,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Prednisolone</span></span></span></span></p>"
        },
        {
          "id": 103781,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Liver transplantation</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">A 26-year-old male is evaluated for lethargy, somnolence, and jaundice. He does not take any medication and denies any drug or alcohol use. He is afebrile with normal vital signs. Exam is significant for a tremor and ataxia. He has no hepatomegaly, ascites, or cutaneous signs of chronic liver disease. Eye exam reveals no abnormality. Laboratory studies are significant for ALT 700 U/L, AST 850 U/L, alkaline phosphatase 119 U/L, total bilirubin 15 mg/dL, direct bilirubin 5.9 mg/dL, and INR 6.0. Hemoglobin is 10 g/dL with WBC 10,000/mm^3 and platelets 100,000. Acetaminophen screen is negative. Ceruloplasmin is 16, and 24-hour urine copper is 90 mcg. ANA is 1:20. Serologies for viral hepatitis are negative. Ultrasound of the liver is unremarkable. Which of the following is the best choice for treatment?</span></span></span></span></p>",
      "unique_key": "Q6387042",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199514,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"background-color:white\"><span style=\"color:black\">Ans.</span></span> </strong><strong><span style=\"background-color:white\"><span style=\"color:black\">D. Liver transplantation</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">D. TRUE: The patient has a history consistent with acute fulminant Wilson disease, suggested by his young age, neurologic findings, and psychiatric history. Other features consistent with fulminant Wilson disease include hemolytic anemia, severe coagulopathy, elevated transaminases, normal alkaline phosphatase, low ceruloplasmin, elevated urine copper, and significant jaundice. This is an indication for liver transplantation due to the poor prognosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">A. FALSE: D-penicillamine is an option for chelation of copper in patients with Wilson disease, but the patient has fulminant hepatic failure and chelation is inadequate in this case.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">B. FALSE: Trientine is the first line chelation therapy for most patients with Wilson disease and typically is effective with normalization of liver enzymes within 6 months, although the resolution of neurologic and psychiatric symptoms may take up to 2 years.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">C. FALSE: Prednisolone is used to treat autoimmune hepatitis.</span></span></span></span></p>",
      "correct_choice_id": 103781,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25965,
      "choices": [
        {
          "id": 103806,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Small bowel gangrene </span></span></p>"
        },
        {
          "id": 103807,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ischemic stricture </span></span></p>"
        },
        {
          "id": 103808,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endoscopic marking</span></span></p>"
        },
        {
          "id": 103809,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Fungal enteritis</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Patient with history of PR bleed is found to have this lesion on laparotomy. What does this signify? </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-29-121258.jpg\" style=\"height:304px; width:300px\" /></p>",
      "unique_key": "Q8089753",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199611,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. Endoscopic marking</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Endoscopic tattooing:</span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Localize luminal pathology- Ca, polyp, vascular malformation </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">India ink injected in SUBMUCOSA </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">4 quadrant injection </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Tattoo mark persists for years!</span></span></li>\r\n</ul>",
      "correct_choice_id": 103808,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25967,
      "choices": [
        {
          "id": 103814,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Give IV propofol through same needle</span></span></p>"
        },
        {
          "id": 103815,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IV ketamine through same needle</span></span></p>"
        },
        {
          "id": 103816,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IV lignocaine through same needle</span></span></p>"
        },
        {
          "id": 103817,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Leave it done</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In a gripping Bollywood medical drama, legendary actor Amitabh Bachchan portrays a renowned surgeon, Dr. Arjun Mehra. The scene unfolds in a high-tech operating room where Amitabh&rsquo;s character is ready to perform a complex surgery. The atmosphere is tense, with the surgical team bustling around, preparing for the procedure. The patient is induced with Thiopentone IV through one of the antecubital veins. The atmosphere takes a sudden turn when the patient complains of severe pain engulfing his whole hand. The music intensifies, spotlighting Amitabh Bachchan&rsquo;s concerned expression. What is the next line of management?</span></span></p>",
      "unique_key": "Q7484385",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199673,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. IV lignocaine through same needle</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-29-121259.jpg\" style=\"height:212px; width:900px\" /></strong></span></span></p>",
      "correct_choice_id": 103816,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25969,
      "choices": [
        {
          "id": 103822,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">ILD</span></span></span></span></p>"
        },
        {
          "id": 103823,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Pseudo-restriction </span></span></span></span></p>"
        },
        {
          "id": 103824,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Bronchial asthma </span></span></span></span></p>"
        },
        {
          "id": 103825,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">Pulmonary Hypertension</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">A 41-year-old smoker presents to you with shortness of breath and you decide to do a pulmonary function test. Interpret his reports?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-30-112140.jpg\" style=\"height:272px; width:700px\" /></span></span></span></span></p>",
      "unique_key": "Q2293160",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199678,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"background-color:white\"><span style=\"color:black\">Ans.</span></span> </strong><strong><span style=\"background-color:white\"><span style=\"color:black\">B. Pseudo-restriction</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"color:black\">The reports are consistent with COPD (FEV1/FVC &lt; 70% after bronchodilator) and the likely underlying cause is emphysema (in view of low DLCO). Also there is significant drop in FVC with TLC being high which is suggestive of pseudo-restriction because of air trapping (evident by high RV)</span></span></span></span></p>",
      "correct_choice_id": 103823,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25971,
      "choices": [
        {
          "id": 103830,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Jackson Pratt drain</span></span></p>"
        },
        {
          "id": 103831,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Romovac drain</span></span></p>"
        },
        {
          "id": 103832,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Tissue expander</span></span></p>"
        },
        {
          "id": 103833,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Chemo-port</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the device:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-30-112142.jpg\" style=\"height:185px; width:400px\" /></span></span></p>",
      "unique_key": "Q8768177",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199700,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. Tissue expander</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Tissue expansion is the creation of extra skin and soft tissue by using a subcutaneous silicone balloon in order to reconstruct locoregional defects. </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The tissue expander is placed within a subcutaneous pocket and then inflated with saline solution at regular (e.g. weekly) intervals via a filling port (which can be buried or externalised). </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The overlying skin and soft tissue have viscoelastic properties; in response to the underlying mechanical force, they permanently elongate through the processes of &lsquo;creep&rsquo; and stress relaxation. Angiogenesis leads to increased vascularity within the expanded skin fap and the local response to a &lsquo;foreign body&rsquo; creates a fibrous capsule. Thus large faps can be created that have similar physical and mechanical properties to the skin that is to be replaced. </span></span></li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Common indications include scalp reconstruction following skin cancer excision, breast reconstruction following mastectomy and auricular reconstruction.</span></span></li>\r\n</ul>",
      "correct_choice_id": 103832,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25974,
      "choices": [
        {
          "id": 103842,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atenolol </span></span></p>"
        },
        {
          "id": 103843,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bethanechol </span></span></p>"
        },
        {
          "id": 103844,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prazosin </span></span></p>"
        },
        {
          "id": 103845,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reserpine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chetan, a patient in the emergency department, presents with severe drug-induced hypotension, registering a blood pressure of 75/50 mmHg. Over the years, you have managed acute hypotension from various causes using an intravenous injection of x mg of methoxamine. Given Chetan&#39;s medical history of taking his current medication for several months, and considering he shows no signs of volume depletion or hemorrhage, you administer the standard dose of methoxamine. Surprisingly, Chetan&#39;s response is unexpected and intense, causing his blood pressure to soar to 180/110 mmHg. Given this stark elevation in blood pressure post-administration, which of the following medications did Chetan most likely overdose on? </span></span></p>",
      "unique_key": "Q9508847",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199753,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. D. Reserpine</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Chronic use of reserpine depletes the storage of catecholamines in presynaptic vesicles, leading to reduced neurotransmitter release. As a compensatory mechanism, the body upregulates postjunctional &alpha;1-adrenergic receptors. When an &alpha;1-adrenergic agonist like methoxamine is administered, the response is intensified due to these upregulated receptors.</span></span></p>",
      "correct_choice_id": 103845,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25976,
      "choices": [
        {
          "id": 103850,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Norepinephrine plus phentolamine </span></span></span></span></p>"
        },
        {
          "id": 103851,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine (at a very high dose)</span></span></span></span></p>"
        },
        {
          "id": 103852,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ephedrine plus propranolol </span></span></span></span></p>"
        },
        {
          "id": 103853,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylephrine plus atropine</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During your rural posting after the internship, you encounter a patient of acute cardiac failure. Your preferred drug for this condition is dobutamine. However, it is not available there. Which of the following other drugs, or combination of drugs, would be a suitable alternative, giving the pharmacologic equivalent of what you want the dobutamine to do? </span></span></p>",
      "unique_key": "Q9219492",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199835,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A. Norepinephrine plus phentolamine</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dobutamine&#39;s primary action is increased cardiac contractility due to &beta;1 stimulation without substantially increasing heart rate or systemic vascular resistance. The desired effects in acute heart failure would be improved cardiac output without significantly raising systemic vascular resistance, which would further tax the heart.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">a. Norepinephrine plus phentolamine:</span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Norepinephrine is an agonist of alpha 1, alpha 2 and beta 1 receptors. It increases systemic vascular resistance significantly through &alpha;1 agonism and also increases cardiac contractility and heart rate through &beta;1 agonism. </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Phentolamine is a non-selective &alpha;-adrenergic antagonist that would counteract the vasoconstrictive effects of norepinephrine.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The combination would lead to increased cardiac contractility and possibly heart rate without substantial increases in vascular resistance. By antagonising the alpha 1 and alpha 2 actions of norepinephrine by phentolamine, this combination gives only beta 1 action that closely mimics the effects of dobutamine.</span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">b. Dopamine (at a very high dose):</span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">At high doses, dopamine stimulates &alpha;-adrenergic receptors leading to vasoconstriction. While dopamine can increase cardiac contractility at intermediate doses, at very high doses, the increased systemic vascular resistance due to &alpha;-adrenergic stimulation does not mimic the action of dobutamine.</span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">c. Ephedrine plus propranolol:</span></span></p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This combination would not mimic the action of dobutamine as desired.</span></span><br />\r\n\t&nbsp;</li>\r\n</ol>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">d. Phenylephrine plus atropine:</span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This combination would primarily increase heart rate (from atropine) and systemic vascular resistance (from phenylephrine) without having a primary effect on cardiac contractility.</span></span></li>\r\n</ul>",
      "correct_choice_id": 103850,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25978,
      "choices": [
        {
          "id": 103858,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3, 4</span></span></p>"
        },
        {
          "id": 103859,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2</span></span></p>"
        },
        {
          "id": 103860,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, 3, 4, 5</span></span></p>"
        },
        {
          "id": 103861,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5, 6</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Which of the following is true regarding the vaccine vial monitor (VVM)? </span></span></p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It is used for monitoring heat exposure of the vaccine by healthcare workers in primary healthcare.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It shows cumulative exposure of the vaccine to the heat.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It can be used to assess the potential efficacy of the vaccine.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Calculation of the expiry date can be done using VM.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The expiry date of the vaccine can be relaxed if VM is in an acceptable range.</span></span></li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the square and the circle are the same in color, then the vaccine can be safely used. </span></span></li>\r\n</ol>",
      "unique_key": "Q9116875",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199938,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. 1, 2</strong></span></span></p>",
      "correct_choice_id": 103859,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25980,
      "choices": [
        {
          "id": 103866,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Complete androgen insensitivity syndrome</span></span></p>"
        },
        {
          "id": 103867,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Mayer Rokitansky K&uuml;ster Hauser syndrome</span></span></p>"
        },
        {
          "id": 103868,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Partial androgen insensitivity syndrome</span></span></p>"
        },
        {
          "id": 103869,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Gonadal dysgenesis</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A young female presented to you with primary amenorrhea. Examination reveals normal breast development and absent axillary and pubic hairs. Pelvic examination shows a normally developed vagina with clitoromegaly and micro-phallus. On ultrasound, masses are visible in the inguinal region. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q6563323",
      "question_audio": null,
      "question_video": null,
      "map_id": 1199960,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. </strong><strong>Partial androgen insensitivity syndrome</strong></span></span></p>",
      "correct_choice_id": 103868,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25983,
      "choices": [
        {
          "id": 103878,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Polyostotic fibrous dysplasia</span></span></p>"
        },
        {
          "id": 103879,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ollier disease</span></span></p>"
        },
        {
          "id": 103880,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Mafucci disease</span></span></p>"
        },
        {
          "id": 103881,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Osler-Weber-Rendu syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the likely diagnosis based on the images shown?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-30-112148.jpg\" style=\"height:236px; width:400px\" /></span></span></p>",
      "unique_key": "Q8229199",
      "question_audio": null,
      "question_video": null,
      "map_id": 1200003,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>C. Mafucci disease</strong></span></span></p>",
      "correct_choice_id": 103880,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25984,
      "choices": [
        {
          "id": 103882,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypermetabolic syndrome </span></span></p>"
        },
        {
          "id": 103883,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nutritional replenishment </span></span></p>"
        },
        {
          "id": 103884,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paraneoplastic syndrome </span></span></p>"
        },
        {
          "id": 103885,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sepsis</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">58-year-old, previously healthy man is evaluated due to a 2-month history of early satiety, postprandial epigastric pain and vomiting and unintended weight loss. Physical examination shows cachexia and palpable epigastric mass. Upper gastrointestinal endoscopy reveals a large prepyloric mass causing gastric outlet obstruction; biopsy of the mass is consistent with poorly differentiated adenocarcinoma. Abdominal CT scan reveals thickening of the gastric wall with adjacent fat infiltration, enlarged lymph nodes, and multiple hepatic metastatic lesions. The disease is considered unresectable, and the patient undergoes laparoscopic gastrojejunostomy for palliation of gastric outlet obstruction. Postoperatively, he tolerates tube feeding but experiences worsening weakness. The patient also has frequent episodes of non-sustained ventricular tachycardia. Laboratory results are as follows:</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/screenshot-2023-09-30-112149.jpg\" style=\"height:365px; width:700px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most likely cause of this patient&#39;s worsening condition?</span></span></p>",
      "unique_key": "Q2377092",
      "question_audio": null,
      "question_video": null,
      "map_id": 1200004,
      "difficulty_level": "difficult",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. </strong><strong>Nutritional replenishment</strong></span></span></p>",
      "correct_choice_id": 103883,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25987,
      "choices": [
        {
          "id": 103894,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Enveloped ss RNA</span></span></p>"
        },
        {
          "id": 103895,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Naked ss RNA</span></span></p>"
        },
        {
          "id": 103896,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Naked ds RNA</span></span></p>"
        },
        {
          "id": 103897,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Enveloped ds RNA</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">An unimmunized 2-year-old child presented with coryza, conjunctivitis, and bluish-white spots in his buccal mucosa near the lower molar teeth. A day later, he developed a maculopapular rash on the face and neck. What is the nature of the causative virus?</span></span></p>",
      "unique_key": "Q9224916",
      "question_audio": null,
      "question_video": null,
      "map_id": 1200027,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. </strong><strong>A. Enveloped ss RNA</strong></span></span></p>",
      "correct_choice_id": 103894,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}